Citizendia

Intravenous immunoglobulin (IVIG) is a blood product administered intravenously. Intravenous therapy or IV therapy is the giving of Liquid substances directly into a Vein. It contains the pooled IgG immunoglobulins (antibodies extracted from the plasma of over a thousand blood donors). Immunoglobulin G ( IgG) is a Monomeric Immunoglobulin, built of two heavy chains γ and two light chains. Antibodies (also known as immunoglobulins, abbreviated Ig) are Gamma globulin Proteins that are found in Blood or other Bodily Antibodies (also known as immunoglobulins, abbreviated Ig) are Gamma globulin Proteins that are found in Blood or other Bodily Blood plasma is the Liquid component of Blood, in which the Blood cells are suspended IVIG's effects last between 2 weeks and 3 months. It is mainly used as treatment in three major categories:

Contents

Mechanism of action

IVIG is given as a plasma protein replacement therapy (IgG) for immune deficient patients which have decreased or abolished antibody production capabilities. Antibodies (also known as immunoglobulins, abbreviated Ig) are Gamma globulin Proteins that are found in Blood or other Bodily In these immune deficient patients, IVIG is administered to maintain adequate antibodies levels to prevent infections and confers a passive immunity. Antibodies (also known as immunoglobulins, abbreviated Ig) are Gamma globulin Proteins that are found in Blood or other Bodily An infection is the detrimental Colonization of a host Organism by a foreign Species. Treatment is given every 3-4 weeks. In the case of patients with autoimmune disease, IVIG is administered at a high dose (generally 1-2 grams IVIG per kg body weight) to attempt to decrease the severity of the autoimmune disease.

The precise mechanism by which IVIG suppresses harmful inflammation has not been definitively established but is believed to involve the inhibitory Fc receptor. Inflammation ( Latin, inflamatio, to set on fire is the complex biological response of vascular tissues to harmful stimuli such as Pathogens An Fc receptor is a protein found on the surface of certain cells - including Natural killer cells Macrophages Neutrophils and Mast cells - that [1][2] The actual primary target(s) of IVIG in autoimmune disease are still unclear, however. IVIG may work via a multi-step model where the injected IVIG first forms a type of immune complex in the patient. [3] Once these immune complexes are formed, they interact with activating Fc receptors on dendritic cells[4]which then mediate anti-inflammatory effects helping to reduce the severity of the autoimmune disease or inflammatory state.

Additionally, the donor antibody may bind directly with the abnormal host antibody, stimulating its removal. Alternatively, the massive quantity of antibody may stimulate the host's complement system, leading to enhanced removal of all antibodies, including the harmful ones. Antibodies (also known as immunoglobulins, abbreviated Ig) are Gamma globulin Proteins that are found in Blood or other Bodily The complement system is a Biochemical cascade that helps clear Pathogens from an organism IVIG also blocks the antibody receptors on immune cells (macrophages), leading to decreased damage by these cells, or regulation of macrophage phagocytosis. Macrophages ( Greek: "big eaters" from makros "large" + phagein "eat" ( Mø) are cells within the tissues that Phagocytosis is the cellular process of engulfing solid particles by the Cell membrane to form an internal Phagosome, or "food vacuole

IVIG may also regulate the immune response by reacting with a number of membrane receptors on T cells, B cells, and monocytes that are pertinent to autoreactivity and induction of tolerance to self. T cells belong to a group of White blood cells known as Lymphocytes, and play a central role in Cell-mediated immunity. B cells are Lymphocytes that play a large role in the humoral immune response (as opposed to the cell-mediated immune response, which is governed by Monocyte is a type of Leukocyte, part of the Human body 's Immune system. [5]

A recent report stated that IVIG application to activated T cells leads to their decreased ability to engage microglia. T cells belong to a group of White blood cells known as Lymphocytes, and play a central role in Cell-mediated immunity. Microglia are a type of Glial cell that acts as the first and main form of active immune defense in the Central nervous system (CNS As a result of IVIG treatment of T cells, the findings showed reduced levels of tumor necrosis factor-alpha and interleukin-10 in T cell-microglia co-culture. Tumor necrosis factor ( TNF, cachexin or cachectin and formally known as Tumor necrosis factor-alpha) is a Cytokine involved in systemic Interleukin -10 (IL-10 or IL10 also known as human cytokine synthesis inhibitory factor (CSIF is an anti- Inflammatory Cytokine. The results add to the understanding of how IVIG may affect inflammation of the central nervous system in autoimmune inflammatory diseases. Autoimmunity is the failure of an organism to recognize its own constituent parts as self, which results in an immune response against its own cells and tissues [6]

IVIG is useful in some acute infection cases such as in Kawasaki's Disease and pediatric HIV infection. Kawasaki disease Pediatrics (also spelled paediatrics) is the branch of Medicine that deals with the medical care of Infants Children and Adolescents Human immunodeficiency virus ( HIV) is a Lentivirus (a member of the Retrovirus family that can lead to acquired immunodeficiency syndrome

IVIG notes

Uses of IVIG

Dosage of IVIG is dependent on indication.

For primary immune dysfunction 100 to 400 mg/kg of body weight every 3 to 4 weeks is implemented.

For neurological and autoimmune diseases 2 grams per kilogram of body weight is implemented for three to six months over a five day course once a month. Then maintenance therapy of 100 to 400 mg/kg of body weight every 3 to 4 weeks follows.

FDA-approved indications

In 2004 the FDA approved the Cedars-Sinai IVIG Protocol which has been 90-95% successful in removing antibodies from the blood of kidney transplant recipients so that they can accept a living donor kidney from any healthy donor no matter blood type (ABO incompatible) or tissue match. Chronic lymphocytic leukemia (also known as "chronic lymphoid leukemia" or "CLL" is a type of Leukemia, or cancer of the white blood cells ( Lymphocytes Idiopathic thrombocytopenic purpura (ITP is the condition of having a low Platelet count ( Thrombocytopenia) of no known cause ( Idiopathic) Kawasaki disease Kidney transplantation or renal transplantation is the Organ transplant of a Kidney in a patient with End-stage renal disease.

Off-label Uses

Complications and side effects

Complications of IVIG therapy include

References

  1. ^ [1]James E. Pulmonary Edema (American English or oedema (British English is swelling and/or fluid accumulation in the Lungs It leads to impaired gas exchange and may cause Oncotic pressure in the Circulatory system is a form of Osmotic pressure exerted by Proteins in Blood plasma that normally tends to pull Allergy is a disorder of the Immune system often also referred to as Atopy. Anaphylaxis is an acute systemic (multi-system and severe Type I Hypersensitivity allergic reaction in humans and other Mammals Hepatitis (plural hepatitides) implies injury to the Liver characterized by the presence of Inflammatory cells in the tissue of Acute renal failure ( ARF) also known as acute kidney failure or acute kidney injury, is a rapid loss of Renal function due to damage to the A venous thrombosis is a Blood clot that forms within a Vein. Aseptic meningitis, or sterile meningitis is a condition in which the layers lining of the brain or Meninges, become inflamed and a Pyogenic Bacterial Gern, MD. "Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor" PEDIATRICS Vol. 110 No. 2 August 2002, pp. 467-468
  2. ^ [2] Falk Nimmerjahn and Jeffrey V. Ravetch. "The antiinflammatory activity of IgG: the intravenous IgG paradox". The Journal of Experimental Medicine, Vol. 204, No. 1, 11-15
  3. ^ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=539209 Raphael Clynes Immune complexes as therapy for autoimmunity. J Clin Invest. 2005 January 3; 115(1): 25–27. doi: 10. 1172/JCI200523994. PMID: 15630438
  4. ^ http://www.ncbi.nlm.nih.gov/pubmed/16715090 Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med. 2006 Jun;12(6):688-92. PMID: 16715090
  5. ^ Bayry J, Thirion M, Misra N, Thorenoor N, Delignat S, Lacroix-Desmazes S, Bellon B, Kaveri S, Kazatchkine MD. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci. 2003; 24: S217–S221.
  6. ^ Janke AD, Yong VW. Impact of IVIG on the interaction between activated T cells and microglia. Neurol Res. 2006 Apr;28(3):270-4. PMID 16687052
  7. ^ Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007;35(12):2686-92. PMID 18074465

5. Noah S Scheinfeld. Intravenous Immunoglobulin. Emedicine. http://www.emedicine.com/med/topic3546.htm


© 2009 citizendia.org; parts available under the terms of GNU Free Documentation License, from http://en.wikipedia.org
Dapyx Software network: MP3 Explorer | Ebook Manager | Zenithic